Summary by Moomoo AI
The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034615 and file number 333-272749, was categorized under the submission type POS AM. This notice of effectiveness by the SEC is a significant step for 180 Life Sciences Corp., indicating that the regulatory body has reviewed and accepted the company's submission.
